Old Web
English
Sign In
Acemap
>
Paper
>
LBP-505 - Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
LBP-505 - Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
2017
Alison D. Marshall
Stine Nielsen
Evan B. Cunningham
Alessio Aghemo
Hannu Alho
Markus Backmund
Philip Bruggmann
Olav Dalgard
Robert Flisiak
Graham R. Foster
L. Gheorghe
David S. Goldberg
Ioannis Goulis
Matthew Hickman
P. Hoffmann
Ligita Jancoriene
Peter Jarčuška
Martin Kåberg
Jason Grebely
Keywords:
interferon free
direct acting
Bioinformatics
Medicine
Virology
Diabetes mellitus
Reimbursement
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]